Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Intercure Ltd (INCR-U.TO)

Intercure Ltd (INCR-U.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Intercure Ltd 85 Medinat ha-Yehudim Street Herzliya 4676670 ISR

https://www.intercure.co P: 972-774-6050

Sector:

Medical

INDUSTRY GROUPING:

TSX Drug Specialty & Generic

Description:

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Key Statistics

Overview:

Market Capitalization, $K 67,025
Shares Outstanding, K 45,573
Annual Sales, $ 238,845 K
Annual Net Income, $ -67,795 K
Last Quarter Sales, $ 102,439 K
Last Quarter Net Income, $ 4,883 K
% of Institutional Shareholders 4.52%

Growth:

1-Year Return -75.36%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 92.97%

Per-Share Information:

Most Recent Earnings 0.01 on 05/16/23
Next Earnings Date N/A
Earnings Per Share ttm 0.62
EPS Growth vs. Prev Qtr -97.37%
EPS Growth vs. Prev Year 8.00%
Dividend Payout Ratio 0.00%

INCR-U.TO Ratios

Ratio
Price/Earnings ttm 9.75
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -15.91%
Return-on-Assets % -9.50%
Profit Margin % -28.38%
Debt/Equity 0.35
Price/Sales 0.70
Price/Book 0.54
Book Value/Share 2.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar